Familial Amyotrophic Lateral Sclerosis (F-ALS) is an incurable, late onset motor 2 neuron disease, linked strongly to various causative genetic loci. ALS8 codes for a 3 missense mutation, P56S, in VAMP-associated Protein B (VAPB) that causes the protein 4 to misfold and form cellular aggregates. Uncovering genes and mechanisms that affect 5 aggregation dynamics would greatly help increase our understanding of the disease and 6 lead to potential therapeutics. 7
Increase in VAP, but not VAP(P58S) levels, appears to elevate ROS, which may in turn 23
regulate VAP transcription in a feedback loop. 24
We have thus uncovered an interesting interplay between SOD1, ROS and TOR 25 signalling that regulates the dynamics of VAP aggregation. Mechanistic processes 26 underlying such cellular regulatory networks will lead us to a better understanding of 27 initiation and progression of ALS. 28 5 proteostasis. We used the previously described (C155-Gal4;UAS-VAP(P58S)) system 94 (RATNAPARKHI et al. 2008; DEIVASIGAMANI et al. 2014) to validate one such modifier, SOD1, 95 in vivo, in the third instar larval brain of Drosophila by measuring changes in aggregation 96 of VAP(P58S) in response to modulation of SOD1 levels. Our data indicates that 97 clearance of VAP(P58S) aggregates via the proteasomal machinery is enhanced by 98 inducing reactive oxygen species (ROS) due to loss of SOD1 function. We also find a 99 similar clearance of aggregation, attributed to proteasomal degradation, with mTOR 100 downregulation accompanied by elevated ROS. We find that wild type VAP, but not 101 mutant VAP, elevates ROS. Accumulated ROS results in inhibition of endogenous VAP 102 transcription, a phenomenon that may directly affect both familial as well as sporadic ALS 103
pathogenesis. 104 105

Results
107
A Drosophila S2R+ cell culture model to study VAP(P58S) aggregation 108 C-terminal and N-terminal fusions of VAP and VAP(P58S) with GFP were used to 109 transfect cells and generate stable S2R+ lines, as described in Materials & Methods (Fig.  110 1A, Suppl. Fig. 1A ). VAP:GFP showed a non-nuclear, reticular localization in the cell with 111 <10% of the transfected (GFP-positive) cells showing high intensity puncta (Fig. 1B,  112 Suppl. Fig. 1A ). In contrast, >80% of the GFP-positive VAP(P58S):GFP, cells showed 113 distinct high intensity puncta with little or no background staining within the cell (Fig. 1C,  114 Suppl. Fig. 1A ). Super resolution imaging confirmed that VAP appeared to be reticular, 115 while VAP(P58S) was found in inclusion bodies (Fig. 1D ). In contrast, GFP, when 116 expressed showed a uniform cytoplasmic signal (Suppl. Fig. 1B ). Both N-terminal GFP 117 fusions, GFP:VAP and GFP:VAP(P58S) showed puncta formation at levels comparable 118 to VAP(P58S):GFP, and hence were not used further in the study (Suppl. Fig. 1A ). All 119 further experiments (see next section) were carried out with stable lines expressing 120 VAP:GFP or VAP(P58S):GFP, which showed expected/relevant localization and levels 121 of aggregation. 122
123
An S2R+ cell based reverse genetics screen is developed to identify modifiers of 124
VAP(P58S) aggregation 125
In an attempt to identify genetic modifiers of VAP(P58S) aggregation kinetics, we 126 conducted a focused S2R+ cell based RNAi screen, targeting 900 unique genes 127 belonging to nine different categories or families associated with ALS or VAP function. 128 7 protein to aggregate. Early time points (12-16 hours) gave very few cells with aggregates; 138 while non-linearity, high confluency, and cell death became a concern at time points 139 beyond 48 hours and concentrations greater than 750 µM. The aggregation kinetics 140 curve was used to define the extent of aggregation in the cell culture system and select 141 optimum parameters to conduct the RNAi screen. Keeping a modest confluency and well-142 separated cells for ease of imaging, the screen was performed at a fixed concentration 143 of 500 µM CuSO 4 at 24 and 36 hours post induction. 144
We chose 900 genes (Suppl . Table 1A ), based on their availability in the Open 145
Biosystems Library (See Materials & Methods) to screen for modifiers that could change 146 aggregation levels of VAP(P58S):GFP. A Gene Ontology (GO) chart ( Fig. 2A) represents 147 the biological process associated with these 900 genes, as defined by FlyBase. The 148 genes were selected and categorized (Suppl. Table 1B) on the following basis. First, 149
known Drosophila Orthologs of ALS loci (20 genes) and ALS related genes (36 genes) 150 as tabulated in the online ALS database (ALSOD) were chosen. The next category 151 included 273 genes from a VAP Drosophila GRN comprising of 406 genes (DEIVASIGAMANI 152 et al. 2014) . As mTOR was identified as a major interactor of VAP in our previous study 153
( DEIVASIGAMANI et al. 2014) , we chose 22 genes of the extended mTOR pathway. To 154 explore the functional aspects of VAP(P58S), we also screened genes involved in lipid 155 biosynthesis (92 genes) and FFAT motif interactors of VAP (34 genes). In order to identify 156 a role of proteostasis in aggregation, we screened genes involved in unfolded protein 157 response (123 genes), ubiquitin-proteasomal pathway (212 genes), and autophagy (88 158
genes) 159
The images collected at the end of the screen (detailed in Materials and Methods) 160 were analysed by an automated MATLAB analysis (see Materials & Methods; Fig. 2B) . 161
Based on average cell intensity, 150 targets (Suppl . Table 1C) , and based on total cell 162 intensity, 85 targets (Suppl. Table 1D ) that modulated VAP(P58S):GFP aggregation 163 kinetics were identified; 55 genes were found to be targets as per both parameters. notably SOD1 and TBPH, were found as interesting modulators perturbing 166 VAP(P58S):GFP aggregation. Targets belonging to the VAP genetic network, as defined 167
by (DEIVASIGAMANI et al. 2014) , were also enriched. As identified earlier (DEIVASIGAMANI et8 al. 2014) , components of the mTOR pathway also appeared to be key regulators of 169 VAP(P58S):GFP aggregation. However, less than 10% of genes screened belonging to 170 families associated with lipid biosynthesis and motif interactors, were identified as targets, 171 suggesting lower functional relevance for VAP(P58S):GFP. Interestingly, genes related 172 to ubiquitin proteasomal system such as ubiquitin ligases and proteasome components 173 were enriched, as were the autophagy related genes such as ATG7 and ATG3. From the 174 unfolded protein response category, along with chaperones such as heat shock proteins, 175
we also identified peptidyl prolyl isomerases as targets. Overall, in our primary targeted 176 screen, we found various genetic interactors of wildtype VAP as modulators of 177 VAP(P58S) aggregation as well; importantly, the uncovering of two ALS loci, SOD1 and 178 TDP-43, mTOR pathway genes such as Rheb and S6K, and genes enriched in ubiquitin 179 proteasomal system as modulators of VAP(P58S) aggregation dynamics, lead us to 180
develop an in vivo model to validate these genes and to understand mechanisms 181 underlying these interactions in the animal. 182
183
A model system for measuring VAP(P58S) aggregation in the Drosophila larval brain. 184
In order to validate targets from the screen in vivo, we used the UAS-GAL4 system 185 to specifically overexpress wild-type VAP or VAP(P58S) in the brain using a pan-neuronal 186 driver, C155 (elav) (RATNAPARKHI et al. 2008; DEIVASIGAMANI et al. 2014) . Based on anti-187 VAP immunostaining, unlike wild-type VAP (Suppl. Fig. 2A ), mutant VAP(P58S) formed 188 distinct cellular puncta and could be used as a model to study aggregation in the animal 189 (Suppl. Fig. 2B-D ). These aggregates have been shown to be ubiquitinated and 190 dominant-negative when expressed in muscle (Ratnaparkhi et al, 2008) . To develop a 191 methodology for quantitation of aggregates in the brain (described in Materials & 192 Methods), we used temperature as a means to increase GAL4 activity, which would 193 increase VAP(P58S) dosage and possibly, aggregation. An increase in mean VAP(P58S) 194 aggregation density was observed from 18 ºC to 25 ºC, but not significantly between 25 195 ºC and 28 ºC (Suppl. Fig. 2H ). Neuronal knockdown of VAP, using RNAi, in CI55-GAL4/+; 196 UAS-VAP(P58S)/+ flies, at each temperature (Suppl. Fig. 2E-G ), led to a significant 197 decrease in corresponding aggregation density of the ventral nerve cord (Suppl. Fig. 2H ). 198
The above experiments suggest that at 25 ºC, we could quantify changes in VAP(P58S)9 aggregation density in the brain of the larvae, and here onwards, we use this system to 200 further validate modifiers of aggregation identified from the cell-based screen. 201
202
Drosophila SOD1 is a modifier of VAP(P58S) aggregation 203
SOD1, first known ALS locus (ROSEN et al. 1993) , has been implicated in both 204 sporadic as well as familial cases and was our first choice for validation of the S2R+ 205 based screen, in the animal. We previously identified SOD1 as a genetic interactor of 206 VAP in a fly-based reverse genetics screen (DEIVASIGAMANI et al. 2014) . Here, we 207 individually knocked down SOD1 using three independent RNAi lines in the CI55-GAL4/+; 208
UAS-VAP(P58S)/+ background and observed a significant decrease in aggregation 209
density in the ventral nerve cord (Fig. 3A, 3B , Suppl. Fig. 3A, 3C, 3D ). This three-fold 210 decrease in VAP aggregates was comparable to the reduction seen with VAP RNAi. 211
Likewise, we overexpressed SOD1 in the CI55-GAL4/+; UAS-VAP(P58S)/+ background. 212
Here, however, we did not find a significant change in aggregation density (Fig. 3C, 3D  213 Suppl. Fig. 3B, 3C, 3E ). Taken together, these results suggest a need for a threshold 214 level of SOD1 to maintain VAP(P58S) inclusions. 215
216
Oxidative stress reduces VAP(P58S) aggregation 217
Enzymatically, SOD1 metabolizes superoxide species to hydrogen peroxide, 218 thereby preventing oxidative stress. A loss of function of SOD1 would, in principle, 219 increase ROS. We tested whether a chemical mimic, paraquat, which increases cellular 220 ROS (CASTELLO et al. 2007; DRECHSEL AND PATEL 2008; COCHEME et al. 2011) , could 221 phenocopy the effect of SOD1 knockdown. We treated the VAP(P58S):GFP stable line 222 with non-lethal concentrations of 10 mM and 20 mM paraquat for 4 hours prior to CuSO 4 223 induction and found that paraquat could significantly reduce the fraction of cells showing 224 GFP positive aggregates (Fig. 4A , Suppl. Fig. 4A ) in a dose-dependent manner. Similarly, 225 larvae with the genotype CI55-GAL4/+; UAS-VAP(P58S)/+ hatched, fed and grown on 226 non-lethal concentration of 5 mM paraquat at 25 ºC, showed a decrease in aggregation 227 density in the third instar larval brain, reminiscent of the SOD1 knockdown phenotype 228 (Fig. 4B, Suppl. Fig. 4B ). We also checked the effect of other ROS scavenging genes 229 such as SOD2 and catalase on VAP(P58S) aggregation. Knockdown of both these genes 230 resulted in a drastic reduction in aggregation density in the ventral nerve cord of CI55-231 GAL4/+; UAS-VAP(P58S)/+ larval brains. As seen with SOD1, overexpression of SOD2 232 did not change aggregation density; however, catalase overexpression resulted in a 233 fractional increase in aggregation density (Suppl. Fig 3F) . These results strongly suggest 234 a ROS dependent maintenance and/or stability of VAP(P58S) aggregates. 235
To confirm whether feeding of paraquat and loss of SOD1 function led to an 236 increase in ROS levels in the larval brain, we measured the levels of oxidized proteins 237 and lipids, using the oxyblot kit and quantitative mass spectrometry based lipidomics, 238 respectively. Using the oxyblot assay, we found that feeding C155-GAL4/+ larvae with 239 increasing concentrations of paraquat (0 mM, 0.05 mM, 0.5 mM, 5 mM) was sufficient to 240 increase ROS in the brain, observed as an increase in intensity of oxidized proteins as 241 compared to unfed larvae (Suppl. Fig. 4C ). As expected, neuronal knockdown of SOD1 242 in presence of VAP(P58S) aggregates, led to a corresponding increase in intensity of 243 oxidized proteins, demonstrating oxidative stress (Fig. 4C) . We found that VAP(P58S) 244 aggregation alone did not significantly change oxidized protein levels as compared to the 245 C155-GAL4/+ control (Fig. 4C) . Unexpectedly, we found that overexpression of VAP in 246 neurons led to a distinct increase in oxidation of proteins (Fig. 4C) . 247
To further bolster our findings, we measured levels of oxidized phospholipids in 248 larval brains (TYURINA et al. 2000; KAMAT et al. 2015; KORY et al. 2017 ). On feeding C155-249 GAL4/+ larvae with 5 mM paraquat, we enriched and detected 9 oxidized 250 polyunsaturated fatty acids (PUFAs), belonging to phosphatidylserine (PS) and 251 phosphatidylethanolamine (PE) (Fig. 4D , Suppl. Table 2 ) families of phospholipids, which 252 were significantly elevated in larval brains, compared to the unfed control. PUFA 253 containing oxidatively damaged phospholipids showed a mass addition of +16 (denoted 254 as ox-) or +18 (denoted as hy-) to the parent phospholipid, as a consequence of addition 255 of different ROS. Of note, the parent or precursor phospholipids did not change in 256 concentration, and the concentrations of the oxidized phospholipids were less than 1% 257 of the parent or precursor phospholipids. We found a similar elevation in concentrations 258 of oxidized phospholipids in C155-GAL4/+; UAS-VAP(P58S)/+; UAS-SOD1_i/+, but not 259 in CI55-GAL4/+; UAS-VAP(P58S)/+ which was equivalent to C155-GAL4/+ control ( Fig.  260 4D, Suppl. Table 2 ). This elevation in oxidized phospholipids was found to be inversely 261 correlated with corresponding fold change in aggregation density (Suppl. Fig. 4D ). 262
Interestingly, we found, as suggested by the oxyblot data, overexpression of VAP had a 263 curious effect of increasing oxidation of lipids, indicating that wild type VAP has a cryptic 264 yet important role in regulating ROS levels. Taken together, these results indicate that 265 ROS initiates processes that aid clearance VAP(P58S) aggregates, and is in turn 266 regulated by VAP wildtype levels in the cell. 267
268
ROS activates proteasomal machinery 269
We further investigated protein degradation mechanisms that may be activated in 270 response to ROS leading to the clearance of VAP(P58S) aggregates. In order to test 271 whether the proteasomal machinery was responsible for reduction in aggregation, we 272 hatched, fed, and grew larvae with proteasomal inhibitor 5µM MG132, and dissected the 273 brains at the wandering third instar stage and analysed the aggregation density. Unfed 274
C155-GAL4/+; UAS-VAP(P58S)/+; UAS-SOD1_i/+, as expected, showed reduced 275
aggregation density (Fig. 5C) , as compared to unfed control (Fig. 5A, 5E ). Upon MG132 276 feeding, C155-GAL4/+; UAS-VAP(P58S)/+; UAS-SOD1_i/+, showed a complete rescue 277 of VAP(P58S) aggregation (Fig. 5D, 5E ). Fed C155-GAL4/+; UAS-VAP(P58S)/+; UAS-278 SOD1_i/+ also showed an enhanced aggregation density as compared to fed CI55-279 (Fig. 5B, 5E ). Aggregates in presence of ROS (with SOD1 280 knockdown) and proteasomal inhibition (with MG132) appeared to be predominantly 281 smaller, scattered and mislocalized around the nuclear membrane/ER as compared to 282 the respective controls (Fig. 5D') . The localization of the aggregates suggest that may be 283 residing in the Juxta Nuclear Quality Control compartment (JUNQ)-like compartment 284 (OGRODNIK et al. 2014) . These results indicate that the proteasomal machinery is 285 facilitated in presence of ROS for active degradation of VAP(P58S) aggregates (Fig 5F) . 286
GAL4/+; UAS-VAP(P58S)/+
However, fed CI55-GAL4/+; UAS-VAP(P58S)/+ larvae (Fig. 5A ) did not show 287 accumulation of aggregation as compared to unfed control (Fig. 5B, 5E observed a drastic clearance of aggregation in the ventral nerve cords as compared to 298 unfed controls (Fig. 6A, 6B, 6C ). When Tor transcripts were reduced using RNAi in CI55-299 GAL4/+; UAS-VAP(P58S)/+, a similar decrease in aggregation density was found (Fig.  300 6D, 6E, 6F). However, when autophagy was induced directly via overexpression of Atg1 301 in CI55-GAL4/+; UAS-VAP(P58S)/+, we did not observe clearance of aggregation (Fig.  302 6G, 6H, 6I). This suggests that mTOR signalling may perturb downstream effectors other 303 than Atg1 which may affect VAP(P58S) aggregation dynamics ( Fig 6J) . 304
mTOR inhibition promotes proteasomal clearance of VAP(P58S) aggregation via ROS 306
We first decided to check whether clearance of aggregates with mTOR inhibition 307 correlated with increase in ROS, as in the case of SOD1 knockdown. We found that levels 308 of several species of oxidized phospholipids were indeed higher with Tor knockdown with 309 or without neuronal overexpression of VAP(P58S) in third instar larval brains to levels 310 similar to SOD1 knockdown (Fig. 7A ). mTOR pathway downregulation has recently been 311
shown to activate not only autophagy but also ubiquitin proteasomal machinery (ZHAO et 312 al. 2015) via Mpk1/ERK5 pathway in yeast and humans (ROUSSEAU AND BERTOLOTTI 313 2016). We tested whether ROS upregulation with Tor knockdown could be inducing 314 proteasomal clearance of VAP(P58S) aggregation by feeding CI55-GAL4/+; UAS-315
VAP(P58S)/+; UAS-TOR_i/+ with 5µM MG132 (Fig 7B, 7C-E). Although there was a 316
significant decrease in aggregation density with Tor knockdown (Fig. 7D) , we found only 317 a slight recovery of aggregation in MG132-fed animals ( Fig. 7E ) as compared to unfed 318 (Fig. 7C ). This recovery appeared to be far 319 less dramatic than that seen in the case of SOD1 knockdown. Taken together, these 320 results indicate that in context of ROS, proteasomal degradation could be the major 321 pathway responsible for clearance of VAP(P58S) aggregation (Fig. 7F) , although other 322 13 downstream effectors of mTOR signalling, including autophagy, cannot be conclusively 323 ruled out as additional mechanisms. 324
CI55-GAL4/+; UAS-VAP(P58S)/+ control flies
We also explored the possible relationship between VAP and ROS at a 325 transcriptional level. Larvae of the control, CI55-GAL4/+ genotype were hatched and fed 326 on 5mM paraquat, and the brains were dissected at the wandering third instar larval stage. 327
The levels of endogenous VAP and SOD1 mRNA, in response to ROS, were measured 328 using qPCR in control larval brains. We found that endogenous VAP mRNA levels were 329 lower in the presence of high levels of ROS (Suppl. Fig. 4E ), while SOD1 mRNA levels 330 remained unchanged (Suppl. Fig. 4F ). This result may indicate the presence of a negative 331 feedback loop wherein VAP overexpression leads to accumulation of ROS ( Fig. 4C-D (ZHANG et al. 2010) . Our screen was aimed at enriching 343 genes that are known players in ALS, VAP interactors and proteostasis. First and 344 foremost, we found ALS loci, SOD1 and TDP-43 as modifiers of VAP(P58S) aggregation, 345 which we had previously identified as VAP genetic interactors (DEIVASIGAMANI et al. 2014) . 346
In this study, we have explored the interaction between SOD1 and VAP, while TDP-43 347 also serves as an exciting candidate for further investigation. TDP-43 has been shown to 348 perturb membrane-associated mitochondrial (TURNER et al. 2008) sites that are 349 maintained by VAPB-PTPIP51 interactions in mammalian cell culture (STOICA et al. 2014) . 350
Additionally, TDP-43 proteinopathy has been identified in motor neurons of mice models 351 of VAP(P58S) aggregation (TUDOR et al. 2010) . TDP-43 driven neurodegeneration has 352 also been shown to be modulated by oxidative stress related MAP kinase pathways in a14 pathway (MOUJALLED et al. 2017) . In addition to SOD1, we have also identified other ROS 355 related genes such as peroxiredoxin V, NADH dehydrogenase, cytochrome c oxidase, 356 that localise to the mitochondria, perturbation of which will lead to oxidative stress, 357 potentially affecting aggregation kinetics of VAP(P58S). 358
Secondly, we enriched a subset of targets involved in protein degradation, UPS 359 and autophagy, an in vivo validation of which would shed light on the how these 360
aggregates are compartmentalized and managed in the neurons. Thirdly, this screen 361 highlighted specific chaperones that could be involved in the misfolding and formation of 362 VAP(P58S) aggregates providing insight into the initiation of the disease condition. Most 363 importantly, through our previous study (DEIVASIGAMANI et al. 2014) , and our cell-based 364 screen followed by subsequent experimentation, we have established mTOR signalling 365 as a strong modulator of VAP(P58S) aggregation. mTOR signalling responds and 366 integrates signals from nutrients, growth factors, energy, and stress, regulates cellular 367 proteostasis, thus contributing to age-related neurodegenerative diseases (PERLUIGI et al. 368 2015) , making it an attractive target for further investigation in ALS pathogenesis. Indeed, 369 rapamycin, a TORC1 inhibitor, is now being used for phase-II clinical trials for ALS 370 (MANDRIOLI et al. 2018) . Lastly, through our screen, targeting processes involved in 371 neurodegeneration, we have identified interactions that point towards a role for VAP as a 372 contributor to a common gene regulatory network (GRN), in agreement with several 373 examples in literature (TUDOR et al. 2010 ; VAN BLITTERSWIJK et al. 2012; PRAUSE et al. 374 2013; DEIVASIGAMANI et al. 2014; STOICA et al. 2014; STOICA et al. 2016; PAILLUSSON et al. 375 2017). When we compared our list of targets with the results from another fly-based 376 screen for VAP(P58S)-induced eye degeneration (SANHUEZA et al. 2015) , we found no 377 overlap, possibly because of differences in sets of genes screened, cell types, and 378 phenotypes visualized. 379
380
An ROS dependant physiological mechanism that triggers proteasomal clearance of 381
VAP(P58S) aggregation 382
In our study, we have used a dosage-dependent pan-neuronal GAL4 expression 383 of VAP(P58S) in order to study changes in aggregation in the third instar larval brain. We 384 found two targets, SOD1 and mTOR (DEIVASIGAMANI et al. 2014) , downregulation of 385 which, led to a decrease in VAP(P58S) aggregation accompanied by oxidative stress. We 386 identified a role of ROS in upregulating the proteasomal machinery and, thereby 387 facilitating the degradation of misfolded VAP(P58S) protein/aggregates (Integrated 388 Model; Fig. 8A ). However, in absence of ROS, we did not find any change in aggregation 389 density upon pharmacological proteasomal inhibition. This is consistent with the cell 390 culture studies that point towards the downregulation of Ubiquitin-proteasome system 391 (UPS) with VAP(P58S) aggregation as a dominant negative effect on wild type VAP 392 function (KANEKURA et al. 2006; GKOGKAS et al. 2008; PAPIANI et al. 2012; GENEVINI et al. 393 2014) . Overexpression of VAP(P58S) or loss of VAP in Drosophila has been shown to 394 enhance ER stress in the adult brains and may be a result of suspended proteasomal 395 degradation (TSUDA et al. 2008; MOUSTAQIM-BARRETTE et al. 2014) . In mice, VAP(P56S) 396
aggregates have been shown to represent an ER-Quality Control (ERQC) compartment 397 that develops as a result of a debilitated ER-Associated Degradative (ERAD) pathway 398 (KUIJPERS et al. 2013) . Indeed, VAP has been shown to interact with UPR sensor AFT6 399 in mice and the ERAD complex thereby regulating proteostasis and lipid homeostasis in 400
HeLa cell lines (Gkogkas et al, 2008; Ernst et al, 2016) . Studies in mammalian cell lines 401 suggest that VAP(P56S) is ubiquitinated, aggregates on the ER membrane and is cleared 402 by the AAA+ valsolin containing protein (VCP)/p97, which interacts with Fas associated 403 factor 1(FAF1) and may use the FFAT motif in FAF1 as an adapter to interact with VAP 404 (PAPIANI et al. 2012; BARON et al. 2014) . In Drosophila, VAP has been shown to be 405 
TOR signaling regulates VAP(P58S) dynamics by a UPS dependent and Atg1 417 independent mechanisms. 418
We previously identified mTOR pathway as a strong regulator of both VAP and 419 VAP(P58S) phenotypes at the neuromuscular junction (DEIVASIGAMANI et al. 2014) . Here, 420
we have shown that inhibition of mTOR pathway also reduces VAP(P58S) aggregation 421 levels in third instar larval brains in presence of ROS. mTOR pathway downregulation is 422 known to activate autophagy (NODA AND OHSUMI 1998), a process that has been shown 423 to reduce mutant huntingtin fragments (RAVIKUMAR et al. 2004 ) and amyloid-β levels 424 (SPILMAN et al. 2010 ) in mice models. Autophagy has been suggested to be upregulated 425 in presence of VAP(P56S) aggregates that also colocalize with the autophagic marker, 426 p62, in mice (LARROQUETTE et al. 2015) . With VAP knockdown in cell culture, autophagy 427 is upregulated due to the loss of calcium homeostasis that arises with the disruption of 428 ER-mitochondrial contact sites (GOMEZ-SUAGA et al. 2017a; GOMEZ-SUAGA et al. 2017b) . 429
However, VAP is also suggested to have a role in autophagosomal biogenesis through 430 direct interaction with autophagy proteins (ZHAO et al. 2018) . In our study, we do not 431 observe any clearance of VAP(P58S) aggregation with activation of Atg1, indicating that 432 clearance observed with mTOR inhibition may be an effect of one or more of its 433 downstream processes (Fig. 8A) . 434 mTOR and SOD1 have been shown to be genetic interactors in Drosophila with 435 mTOR inhibition enhancing the lifespan defect incurred with SOD1 knockdown (SUN et 436 al. 2012) . Recently, mTOR has been directly shown to regulate SOD1 activity by its 437 phosphorylation based on nutrient availability in yeast and mammalian cells (TSANG et al. 438 2018) . Although this phosphorylation site does not appear to be conserved in Drosophila, 439 this study demonstrates the role of mTOR pathway in regulating ROS via SOD1. mTOR 440 inhibition, specifically, mTORC1 has also been shown to activate proteasomal 441 degradation independent of its other targets, such as, 4EBP, S6K and Ulk (CAVANAUGH 442 et al. 2006; ZHAO et al. 2015 ). An evolutionarily conserved regulation of components of 443 proteasomal assembly by mTORC1 via Mpk1/ERK5 has been reported in yeast as well 444
as mammalian cell culture (ROUSSEAU AND BERTOLOTTI 2016). ERK5 signalling has been 445 implicated in neuroprotective roles in response to mild levels of oxidative stress 446 (CAVANAUGH et al. 2006; SU et al. 2014) . These studies suggest that ROS regulation by 447 mTOR inhibition via SOD1 and ERK5, serves as a plausible mechanism for the 448 proteasomal degradation of VAP(P58S) protein/aggregation, and by extension, the 449 rescue of VAP(P58S) NMJ phenotype (DEIVASIGAMANI et al. 2014) (Fig. 8B) . 450
451
Increase in ROS by VAP, but not VAP(P58S) expression 452
SOD1-associated elevation in ROS levels and oxidative stress is suggested as a 453 plausible factor of motor neuron death in ALS (BARBER et al. 2006; SACCON et al. 2013) . 454 Teuling et al., 2007 (TEULING et al. 2007 ) have shown that VAPB protein levels decrease 455 in an age-dependent manner in a mouse model of SOD1-G93A, providing the first 456 evidence of a link between ALS1 and VAP/ALS8. We now find that overexpressed VAP, 457 unlike VAP(P58S), promotes the accumulation of ROS in the system. This is consistent 458 with a study that shows lowered ROS in a vpr (VAP ortholog) mutant of C. elegans in 459 response to increased mitochondrial connectivity and altered function (HAN et al. 2012) . 460 VAP neuronal overexpression in Drosophila has also been shown to increase bouton 461 number (PENNETTA et al. 2002) similar to SOD1 mutant phenotype at the NMJ (MILTON et 462 al. 2011) , and is correlated with increased ROS in both scenarios. VAP may be important 463 in regulating pathways that respond to changes in ROS levels, such as mTOR and ERK 464 pathways that can regulate UPS (ROUSSEAU AND BERTOLOTTI 2016). VAP also modulates 465 ERAD (and UPS), via its interaction with VCP and FAF1 (PAPIANI et al. 2012; BARON et 466 al. 2014) . We hypothesize that the interaction between VAP and ROS could lead to 467 crosstalk between these pathways regulating global proteostasis (Fig. 8B) . 468
469
ROS may regulate VAP levels by regulating VAP transcription 470
In our study, we have found that in presence of ROS, VAP transcription is 471 downregulated in wild type flies. We had previously shown that SOD1 knockdown 472 rescues VAP macrochaetae phenotype (DEIVASIGAMANI et al. 2014) , which may be a 473 consequence of excessive ROS accumulation, and subsequent downregulation of VAP 474 levels and function. Two independent studies (QIU et al. 2013; KIM et al. 2016) , that 475 overexpressed VAPB in ALS1 (SOD1-G93A) mice as an attempt at rescuing ALS 476 defects, found contradictory observations, owing mainly to differences in expression 477 levels of the protein. VAPB mRNA levels are known to be lowered in spinal cords of 478 patients with sporadic ALS (ANAGNOSTOU et al. 2010) , as well as in IPSC-derived motor 479 neurons from ALS8 patients (MITNE-NETO et al. 2007 ). It has also been reported that 480 VAPB staining in motor neurons of sporadic patients is increased showing "punctate 481 accumulation" that colocalize with early endosomal marker, Rab5 (SANHUEZA et al. 2015) . 482
Based on our results and taking into consideration earlier observations (TEULING et al. 483 2007; ANAGNOSTOU et al. 2010; DEIVASIGAMANI et al. 2014) , we submit that in the ALS 484 disease scenario, increased VAP accumulates ROS that initiates a negative feedback 485 loop resulting in downregulation of VAP, at the transcript level (Fig. 8A) . It remains to be 486 tested whether ROS-activated pathways such as MAP kinase pathways or mTOR 487 pathway, could directly control VAP expression. This VAP/ROS regulation that we have 488 uncovered may have significant implications in ALS pathogenesis for both sporadic and 489
familial ALS. 490 491
In Summary, we find that the dynamics of VAP(P58S) neural aggregates, a 492 species intimately linked to disease in the human context, is sensitive to levels of ROS. 493
Change in physiological levels of ROS appear to dictate the equilibrium between the 494 aggregated and non-aggregated forms. The cellular levels of ROS are themselves 495 dictated by well characterized regulatory mechanisms that include ROS generators and 496 scavengers. As shown in this study, TOR signalling and VAP/VAP(P58S) expression 497 levels would contribute to the extent of aggregation, and may act as regulatory feedback 498 loops to regulate physiological ROS levels. SOD1, VAP/ALS8, TOR and ROS are part of 499 physiological regulatory circuit that maintains levels of VAP(P58S) aggregates. 500
Materials & Methods 501
Generation of constructs and dsRNA: The cDNA sequence of VAP and VAP(P58S) 502 mutant were cloned into pRM-GFP plasmid (BHASKAR et al. 2000) to generate both N and 503 C-terminal GFP fusions, using the EcoR1 restriction site. The pRM-GFP vector has GFP 504 cloned into pRM-HA3 vector at the BamHI site. 500 uM CuSO4 was used to drive 505 expression is S2R+ cells after transient transfections. dsRNA for the secondary screen 506 was generated using MEGAscript® T7 Kit (AM1333) by ThermoFisher Scientific. 507
Template for dsRNA was generated by using cDNA as template, prepared from flies. 508
Primers for the same were ordered from Sigma. 509
Handling of Schneider cells: Drosophila S2R+ cells were maintained in Schneider cell 510
Media (#21720-024; GIBCO) with 10% Heat inactivated Fetal Bovine Serum (FBS, 511 #10270; GIBCO). Batches of cells were frozen in 10% DMSO (D2650; Sigma) and stored 512 in liquid nitrogen following DRSC protocol (http://www.flyrnai.org/DRSC-PRC.html). In 513 general, after reviving, cells were discarded after 25-30 passages. Cells were maintained 514 at 23° C, and split every 4 days at a ratio of 1:5. 515
Cell culture and generation of S2R+ stable lines: Stable S2R+ cell lines were generated 516 by co-transfecting with pRM-HA3 constructs of VAP:GFP, VAP(P58S):GFP or GFP along 517 with pCo-Hygro in 20:1 ratio, using Effectene (QIAGEN) and/or Mirus TransIT 2020 (MIR 518 5400), and selected under 250 µg/ml of hygromycin (Sigma) for 10-15 passages. Stable 519 as well as transiently transfected cell lines were induced to express the gene of interest 520 under a metallothionein promoter using increasing concentrations 250μM, 500μM, 750μM 521 and 1000μM of copper sulphate and analysed at 12, 24, 36 and 48 hours post induction. 522
Transient transfections assays were performed using Mirus TransIT-2020 (MIR 5400) 523 transfection reagent. Protocol for dsRNA knockdown assay was modified from (ROGERS 524
AND ROGERS 2008). Fixation, DAPI staining and imaging was done using EVOS FL Auto 525
Cell Imaging system. Super-resolution images of fixed VAP:GFP and VAP(P58S):GFP 526 cells were acquired using Leica SR GSD 3D system. 527
Western blotting: Cells were centrifuged at 3000 rpm for 5 minutes in Eppendorf 5414R 528 centrifuge. The pellet was resuspended in 20 μl of supernatant and boiled with 1X SDS 529
Dye at 95°C. Samples were centrifuged again at 10000 rcf for 10 minutes. Cell extracts 530 were separated by 12% SDS-PAGE and transferred onto 0.45 μm PVDF membrane 531 (Millipore). Membranes were blocked for 1 hour in 5% skimmed milk in 1X TBS containing 532 0.1% Tween-20 at room temperature and probed with 1:10,000 diluted mouse anti-533 Tubulin (T6074; Sigma-Aldrich) and 1:5,000 diluted mouse anti-GFP (Roche life science), 534 overnight at 4 (12 hours). Anti-rabbit and anti-mouse secondary antibodies conjugated 535 to horseradish peroxide (Pierce) were used at a dilution of 1:10,000 for 1 hour at room 536 temperature. Blots were developed with Immobilon Chemiluminescent Substrate 537 (LuminataClassico Western HRP substrate from Millipore) using a LAS4000 Fuji imaging 538
System. 539
GO analysis: The list of genes and Gene Ontology (GO) information was obtained based 540 on Flybase (http://flybase.org) (MARYGOLD et al. 2013) 
pl). 549
High through-put screen, and image acquisition: The screen was performed at the 550 screening facility at CCAMP-NCBS, Bangalore (http://ccamp.res.in/HTS-HCI). dsRNA for 551 the high throughput screen was generated and plated into sixteen 384 well plates by 552
Chromous Biotech, Bangalore in preparation for the experiment. The library used as a 553 template for generating dsRNAs was procured from Open Biosystems (RDM1189 and 554 RDM4220). 50 μl of cells (3 X 10^6 / ml) were plated in each well for the 384 well flat 555 bottom plates obtained from Corning. Each target dsRNA knockdown experiment was 556 done in triplicate, randomly arranged in the 384 well plate. The cells were treated with 10 557 μg/ml of dsRNA for 48 hours, followed by induction with 500 μM CuSO 4 . The cells were 558 fixed and imaged at 24 and 36 hours post CuSO 4 induction. Fixation was done with 4% 559 PFA in 1X PBS, washed twice with 1X PBS, treated with 0.05µg/ml DAPI and followed 560 with two washes with 1X PBS. Each plate contained 7 negative controls occupying 42 561 wells. 114 unique genes were screened in each plate. Few genes were kept as overlap 562 21 between multiple plates to check for their consistency and reproducibility. Imaging for the 563 high throughput screen was performed by THERMO Array Scan VTI HCS system. Dual-564 channel images from ten fields in each well were captured using a 20X air objective and 565 an EMCCD camera. The FITC (488nm) channel was used for imaging VAP(P58S):GFP 566 aggregates and the DAPI (405nm) channel for imaging cell nuclei. 10 fields were imaged 567 in each well and around 400 cells were imaged per field. In well triplicates, around 12,000 568 cells were imaged for each dsRNA knockdown. 569
High throughput data analysis: Images from the FITC and DAPI channels in each site 570 were read using the Bio-Formats MATLAB toolbox (LINKERT et al. 2010 ) and were 571 processed using custom MATLAB scripts. The segmentation was done using the DAPI 572 images and the extraction of pixel intensities was done on the FITC channel. Illumination 573 correction was performed as a pre-processing step on the DAPI Images and individual 574 nuclei were segmented after a contrast stretching routine was applied. The identified 575 objects were further filtered for outliers, based on a size-based cutoffs and the individual 576 8-connected components were labelled as separate nuclei. Under 20x magnification we 577 estimated the cellular radius to be around 10 pixels corresponding to 5 μm. Thus, labelled 578 cellular objects (ROIs), were obtained by dilating the centroids of each nuclei by 10 pixels. 579
Around 400 ROIs were obtained from each field consistent with manually counted cells 580 in these images. The resultant ROI's were further filtered for clumps and out of focus 581 objects. The GFP intensities were obtained for these ROI's post a local background 582 correction of the FITC images (with a disk size of 3 pixels). Average and total intensities 583 were calculated from the pixel data obtained from every cell/ROI from these FITC images. 584
A Kolmogorov-Smirnov-like (KS) statistic was used to assign Z-scores to each gene on 585 plate as reported by (DEY et al. 2014) . A statistically significant threshold was obtained 586 for the triplicate data using monte-carlo simulations. Genes were classified as hits, if it 587 occurred two or more times above a given Z-score threshold. The false positive rates for 588 both parameters at both time points was zero. The false negative rates for average 589 intensity for 24 hours-time point was 0.2523 and for 36 hours-time point was 0.361. The 590 false negative rates for total intensity for 24 hours-time point was 0.3838 and for 36 hours-591 time point was 0.3164. 592
22
Fly husbandry and brain aggregation assay: Fly lines were maintained on standard corn 593 meal agar medium. UAS-GAL4 system was used for overexpression of transgenes. UAS-594 VAP wildtype, UAS-VAP(P58S) and C155-GAL4 lines used for fly experiments have 595 been described earlier (RATNAPARKHI et al. 2008; DEIVASIGAMANI et al. 2014) . Canton S 596 flies were used as wildtype control. UAS-VAP_i (27312), UAS-SOD1_i (34616, 29389, 597 36804) and UAS-TOR_i (35578) where the suffix 'I' indicates an RNAi line, and UAS-598 SOD1 (24750, 33605) were obtained from BDSC. Clone for UAS-FLAG-HA tagged 599 SOD1 in pUASt vector was obtained for expression in Drosophila from DGRC and 600 injected in the NCBS-CCAMP transgenic facility. UAS-Atg1 line was kindly provided by 601 Dr. Chen, Academia Sinica; the line was validated in the wing using ptc-GAL4 as 602 described (CHEN et al. 2008) . Experimental Crosses were set at 18°C, 25°C or 28°C, as 603 indicated. Brains were dissected from third instar larvae and processed for 604 immunostaining assay. 4% paraformaldehyde containing 0.1% Triton-X was used for 605 fixation followed by washes with 1X PBS. Blocking treatment and washes were 606 performed with 0.3% Triton-X with 2% BSA. Brains were stained with 1:500 diluted anti-607 VAP antibody and 1:1000 anti-rabbit secondary (Invitrogen) was used. Z-stacks of five-608 ten brains for each sample were imaged under 63X oil objective of Ziess LSM 710 609
Confocal Microscope. The number of aggregates were quantified per cubic micron of the 610 ventral nerve cord, defined as "aggregation density" using the Huygen professional 611 software. The high intensity puncta were considered as aggregates. An arbitrary 612 threshold was set for controls as well as for test samples that achieved removing low 613 intensity background signal emitted by the tissue, along with separation of high intensity 614 puncta that were adjacent to one another. An object filter was used to remove objects of 615 size greater than 1000 pixels and garbage size smaller than 10 pixels was excluded. 616
Three 3D region of interests of fixed size were drawn along the tip of the ventral nerve 617 cord and the number of aggregates were counted from each of these ROIs and averaged 618 for each animal. The volume (in cubic micron) of ROI depicting the thickness of the brain 619 tissue was measured as the range of the z-stack of the image. The aggregation density 620 obtained for each brain has been normalised to the mean of the control group, C155-621
GAL4; UAS-VAP(P58S) (+ 0.25% DMSO, in case of DMSO-soluble drug experiments)
23 and plotted as "normalized aggregation density" in each graph. Student t-test and one-623 way ANOVA were used to measure statistical significance. 624
Drug treatment: Cells were exposed to 10mM and 20mM Paraquat dichloride hydrate 625 (500mM, 36541-Sigma-aldrich) for 24 hours prior to protein induction with 500µM copper 626 sulphate. Fixation, DAPI staining and imaging was done using EVOS FL Auto Cell 627
Imaging system. For flies, 10-12 virgins were placed with CS males, for each genotype 628 and animals were allowed to mate for 24 hours and transferred to standard cornmeal fly 629 media containing paraquat (0.05mM, 0.5mM, and 5mM), MG132 (5µM), rapamycin 630 at 2800 x g for 5 minutes. The organic phase (bottom) was removed, 50 μL of formic acid 646 was added to acidify the aqueous homogenate (to enhance extraction of phospholipids), 647
and CHCl 3 was added to make up 4 mL volume. The mixture was vortexed, and separated 648 using centrifugation described above. Both the organic extracts were pooled, and dried 649 under a stream of N 2 . The lipidome was re-solubilized in 200 μL of 2:1 (vol/vol) CHCl 3 : 650 MeOH, and 20 μL was used for the targeted LC-MS analysis (KAMAT et al. 2015) . All the 651 phospholipid species analyzed in this study were quantified using the multiple reaction 652 monitoring (MRM) method on an AbSciex QTrap 4500 LC-MS with a Shimadzu Exion-LC24 series quaternary pump. All data was collected using the Acquisition mode of the Analyst 654 software, and analyzed using the Quantitate mode of the same software. The LC 655 separation was achieved using a Gemini 5U C-18 column (Phenomenex, 5 μm, 50 x 4. performed using an electrospray ion source, using the following MS parameters: ion 663 source = turbo spray, collision gas = medium, curtain gas = 20 L/min, ion spray voltage = 664 4500 V, temperature = 400 o C. A typical LC-run consisted of 55 minutes, with the following 665 solvent run sequence post injection: 0.3 ml/min 0% buffer B for 5 minutes, 0.5 ml/min 0% 666 buffer B for 5 minutes, 0.5 ml/min linear gradient of buffer B from 0 -100% over 25 667 minutes, 0.5 ml/min of 100% buffer B for 10 minutes, and re-equilibration with 0.5 ml/min 668 of 0% buffer B for 10 minutes. A detailed list of all the species targeted in this MRM study, 669 describing the precursor parent ion mass and adduct, the product ion targeted can be 670 found in Suppl. Table 2. All the endogenous lipid species were quantified by measuring 671 the area under the curve in comparison to the respective internal standard, and then 672 normalizing to the number of larval brains. All oxidized phospholipids detected were 673 normalized to the corresponding unoxidized phospholipid internal standard. All the data 674 is represented as mean ± s. e. m. of 4 biological replicates per genotype. 675 mRNA isolation, cDNA preparation and qRT PCR: About 1 µg of mRNA was isolated from 676 12-18 third instar larval brains using Direct-zol™ RNA MicroPrep Kit (R2062) from Zymo 677
Research. The cDNA reaction was carried out using High Capacity cDNA Reverse 678
Transcriptase Kit (4368814) by Applied Biosystems. The qPCR reaction was carried out 679 using KAPA SYBR FAST (KK4602) by Sigma using Replex Mastercycler by Eppendorf. 680
The experiment was carried out in three biological replicates with technical triplicates. . Table 1A) were chosen for knockdown. GO representation indicates the categories of genes chosen and fraction (%) for each category. Genes were categorized as described in text (Supplementary table 1A, 1B) .
B:
Workflow of the steps executed for image analysis using an automated MATLAB script (Dey et al, 2014) . Steps detailed in Material and Methods. C: The end result of the screen is a list of 150 genes identified based on average cell intensity, which have been found to modify aggregation of VAP (P58S) 
C:
Oxyblot showing increased levels of oxidized proteins in larval brains (N=14) upon SOD knockdown, or VAP overexpression. Values below the gel indicate fold intensity of the strongest band, when compared to control (C155-GAL4/+). Suppl. Fig. 4C shows a calibration for the Oxyblot system, values measured after feeding increasing amounts of Paraquat to larvae. D: Heat map depicting change in levels of oxidized phospholipids normalized to C155-GAL4/+, quantified using MS in response to ROS generated in third instar larval brains (N=4) for the listed genotypes. SOD knockdown as well as VAP overexpression appears to increase cellular ROS levels. Statistical tests are described in Suppl. Kanekura et al., 2005; Kuijpers et al., 2013; 3. Noda and Ohsumi, 1998; Perluigi et al., 2015; 4. Zhao et al., 2015; Rousseau et al., 2016; 5. Sun et al., 2012; Tsang et al., 2018; 6. Gomez-Suaga et al., 2017; Zhao et al., 2018; 7. Deivaisigamini et al., 2014 ; 8. Baron et al., 2014; Papiani et al., 2012; 9. Cavanaugh et al., 2006; Su et al., 2014. VAP ( , and with SOD1-HA:Flag overexpression (E). All images were taken at the same magnification. F: SOD2 or Catalase knockdown reduces aggregation density. Overexpression of SOD2 does not change aggregation density, however overexpression of Catalase increases aggregation density. The '_i' appended to the gene name indicates an RNAi line. ANOVA (P-value: ****<0.0001) Fisher's LSD multiple comparison test (Pvalue, **<0.01, ***<0.001). 
C155-GAL4/+; UAS-VAP(P58S)/+ C155-GAL4/+; UAS-VAP(P58S)/+; UAS-
